Growth hormone‐releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancerLaura Muñoz‐Moreno, Ana M. Bajo, Marı́a J. Carmena et al.|The Prostate|2018Cited by 22
Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer modelsLaura Muñoz‐Moreno, Ana M. Bajo, M. Isabel Arenas et al.|Investigational New Drugs|2014Cited by 18
Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cellsLaura Muñoz‐Moreno, Marı́a J. Carmena, Ana M. Bajo et al.|Molecular and Cellular Endocrinology|2017Cited by 18
Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonistsLaura Muñoz‐Moreno, Ana M. Bajo, Marı́a J. Carmena et al.|Investigational New Drugs|2019Cited by 16
Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancerLaura Muñoz‐Moreno, Ana M. Bajo, M. Isabel Arenas et al.|Oncotarget|2016Cited by 14